The bedside arrival of blockbuster medicines like ibrutinib and osimertinib changed the narrative on oncogene-driven cancers. How? Cysteine. Reporting in 2024, Takahashi et al. comprehensively map the covalently targetable cysteines across 416 cancer models, defining biological and structural principles of target tractability. Welcome to DrugMap.
active 2023-09-28 → 2025-02-18 (UTC)
Activity over time
Daily event counts in the loaded window
Line chart, 510 days from 2023-09-28 to 2025-02-18. Pushes: 179 total, peak 48 in a day. Pull requests: 0 total, peak 0 in a day. Issues: 1 total, peak 1 in a day. Comments: 1 total, peak 1 in a day. Stars: 9 total, peak 2 in a day.
- Pushes
- Pull requests
- Issues
- Comments
- Stars
Top contributors
Pushes, PRs, issues, reviews and comments — stars and forks excluded, so this is contribution rather than popularity
| Contributor | Contributions | Pushes | PRs | Comments |
|---|---|---|---|---|
| bplab-compbio | 180 | 179 | 0 | 1 |
| roivant-matts | 1 | 0 | 0 | 0 |
Recent activity
Latest issues, pull requests and releases
- Issue comment#1bplab-compbio2024-05-20 14:41Data Downloads vs website
- Issue#1roivant-matts2024-05-16 13:54Data Downloads vs website
Totals cover only the window loaded into ClickHouse and count events, not GitHub's lifetime totals — 9 stars here means stars gained during the window, not the repo's star count.